Affiliation:
1. The Eighth Affiliated Hospital of Sun Yat-Sen University
Abstract
Abstract
Nuclear proteins of the testis (NUT) carcinoma resulting from t(15,19) rearrangement is a rare and aggressive carcinoma, which is characterized by primary occur in the midline of body, especially in the upper aerodigestive tract. Due to its poor report and incidence, it is difficult but significant for clinicians to diagnose during patients first visit. Up to now, there has been lack of a standard therapeutic regimen of this lethal disease and a multimodal approach with systemic chemotherapy, surgery and radiation therapy is adopted in clinical practice. Recently, new procedures like BET-inhibition also have been investigated in clinical trials. In this study, we report a case of primary nasal cavity NUT midline carcinoma in a 23-year-old man who had a chief complaint of eye pain and exophthalmos in the left. The initial pathological examination suggested malignant tumor but difficult to make a definite diagnosis. Given the tumor’s wide invasion of sinuses of the whole group, the eye in the left and anterior fossa, we suggest resection and chemotherapy. At present, the patient died 3 months after diagnosis of NUT carcinoma. The present paper reviews the clinical characteristics of NUT carcinoma, the current methods of diagnosis, and treatment of this rare and aggressive disease.
Publisher
Research Square Platform LLC
Reference5 articles.
1. NUT midline carcinoma of the head and neck: current perspectives;Napolitano M;Onco Targets and Therapy,2019
2. Diagnosis of NUT Carcinoma Despite False-Negative Next-Generation Sequencing Results: A Case Report and Literature Review;Xi W;Onco Targets and Therapy,2021
3. Intra–, para–, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus—a case report;Tosic L;Acta Neurochir,2022
4. Cytopathologic Features of NUT Midline Carcinoma: A Series of 26 Specimens From 13 Patients;Bishop JA;Cancer Cytopathol,2016
5. Case Report and Literature Review: Primary Pulmonary NUT-Midline;Yunxiang Z;Carcinoma Front Oncol,2021